This post has been archived and contains information that may be out of date.
Updated Implementation Timeline Announced for Statewide Vaccine Network
Today, the state of California and Blue Shield of California announced in a press release that on March 1:
This post has been archived and contains information that may be out of date.
The Centers for Medicare & Medicaid Services issued the following updates this week:
March 9 Webinar: Q&A Session: CY 2020 eCQM Reporting Using the HQR System
Post-Acute Care Transfers: Bill Correctly
CMS Reopening MIPS EUC application for Individual MIPS Eligible Clinicians, Groups, Virtual Groups, and APM Entities through March 31, 2021 at 5 p.m. PT
CMS Applying MIPS Automatic Extreme and Uncontrollable Circumstances Policy to All MIPS Eligible Clinicians for 2020 Performance Period
This post has been archived and contains information that may be out of date.
On Feb. 22, the California Department of Public Health (CDPH) announced in All Facilities Letter 21-10 that its Centralized Applications Branch (CAB) will begin a paperless process for issuing health care facility licenses, starting March 1.
This post has been archived and contains information that may be out of date.
As Congress continues to deliberate President Biden’s $1.9 trillion COVID-19 relief package, with House approval expected Friday, a new report from financial consulting firm Kaufman Hall paints a troubling picture of the financial toll the pandemic has taken on hospitals.
This post has been archived and contains information that may be out of date.
CHA continues to work with the state’s Government Operations Agency and its third-party administrator (TPA), Blue Shield of California, on the new statewide vaccination network.
Currently, Blue Shield is determining which providers will be in its network, and is doing so in three stages:
This post has been archived and contains information that may be out of date.
The Department of Health and Human Services (HHS) has announced that the monoclonal antibody therapy bamlanivimab and antibody cocktail casirivimab/imdevimab will no longer be allocated to health departments, and that authorized health care providers should order directly from AmerisourceBergen Corporation (ABC), the drugs’ sole distributor. The products remain free of charge to requesting sites.
This post has been archived and contains information that may be out of date.
[embed]To install the latest Zoom update to your PC, MAC or mobile device, do the following:
This post has been archived and contains information that may be out of date.
CHA will be working with the Emergency Medical Services Authority (EMSA) as a member of the Community Paramedicine Advisory Committee.
The committee, which is required by Assembly Bill (AB) 1544 (chapter 138, statutes of 2020), will advise the authority on the development and oversight of community paramedicine programs and triage to alternate destination program specialties established in AB 1344, the Community Paramedicine or Triage to Alternate Destination Act of 2020.
This post has been archived and contains information that may be out of date.
CHA reminds hospitals that preview data for April public reporting are currently available for review through Feb. 26. CHA encourages members to view their hospital-specific preview reports, available on the QualityNet website.
This post has been archived and contains information that may be out of date.
On Feb. 18, CHA testified at the Board of Pharmacy Enforcement and Compounding Committee about member concerns on recent specialty pharmacy payer changes. These policy changes disrupt the traditional buy-and-bill method, where hospitals buy and store specialty drugs for general use and bill payers for the dose used when administered to the patient.